New pill shows promise for untreated brain tumors
NCT ID NCT04458272
First seen Apr 22, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This study tests a new drug, DS-1001b, in 25 people with a slow-growing brain tumor (grade II glioma) that has a specific gene change (IDH1 mutation). Participants have not had chemotherapy or radiation before. The goal is to see if the drug can shrink the tumor and how safe it is.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WHO GRADE II GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hiroshima University Hospital
Hiroshima, Japan
-
Kitasato University Hospital
Sagamihara, Kanagawa, Japan
-
Kumamoto University Hospital
Kumamoto, Japan
-
Kyorin University Hospital
Tokyo, Japan
-
Kyoto University Hospital
Kyoto, Japan
-
Nagoya University Hospital
Nagoya, Aichi-ken, Japan
-
National Cancer Center Hospital
Tokyo, Japan
-
National Hospital Organization Osaka National Hospital
Osaka, Japan
-
Saitama Medical University International Medical Center
Hidaka, Saitama, Japan
-
Tohoku University Hospital
Sendai, Miyagi, Japan
-
Tokyo Women's Medical University Hospital
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.